Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06536933
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-31
Brief Title:
Study of Metabolic Dysfunction-Associated Steatotic Liver Disease Among Sohag University Employees
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Study of Metabolic Dysfunction-Associated Steatotic Liver Disease Among Sohag University Employees
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Metabolic dysfunction-associated steatotic liver disease MASLD is the latest term for steatotic liver disease associated with metabolic syndrome MASLD is a common cause of chronic liver disease and is the leading cause of liver-related morbidity and mortality
The high prevalence of this disease has been fueled by the rapid rise in levels of sedentary behavior low levels of physical activity excess calorie intake relative to expenditure in nutritionally imbalanced and unhealthy diets In parallel the prevalence of poor metabolic health in adults from many countries is high even in normal weight individuals
MASLD has been estimated to affect 30 of the adult population worldwide with its prevalence increasing from 22 to 37 from 1991 to 2019 The increasing prevalence of MASLD parallels the increasing prevalence of obesity and obesity-related diseases
The high prevalence of this disease has been fueled by the rapid rise in levels of sedentary behavior low levels of physical activity excess calorie intake relative to expenditure in nutritionally imbalanced and unhealthy diets In parallel the prevalence of poor metabolic health in adults from many countries is high even in normal weight individuals
MASLD has been estimated to affect 30 of the adult population worldwide with its prevalence increasing from 22 to 37 from 1991 to 2019 The increasing prevalence of MASLD parallels the increasing prevalence of obesity and obesity-related diseases
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None